Compare

Smiths Group/£SMIN

1D1W1M3M6MYTD1Y5YMAX

About Smiths Group

Smiths Group is a British multinational company headquartered in London, United Kingdom. It operates in the engineering sector with a focus on designing, manufacturing, and delivering products and services for various industries, including energy, security, general industrial, and healthcare markets. Key segments include John Crane, providing products for energy and process industries; Smiths Detection, specializing in threat detection and protection; and Smiths Medical, offering medical devices and equipment. Established in 1851, Smiths Group has a global footprint, serving customers in over 50 countries. The company emphasizes innovation and technical expertise as part of its strategic positioning, contributing to its long-standing presence in diverse yet technologically driven markets.
Ticker
£SMIN
Primary listing
LSE
Employees
10,435

Smiths Group Metrics

BasicAdvanced
£7.5B
4.31
£6.26
0.71
£0.47
1.73%

What the Analysts think about Smiths Group

Analyst ratings (Buy, Hold, Sell) for Smiths Group stock.
Analyst projections of the future price of Smiths Group stock.

Bulls say / Bears say

Smiths expects about 4% organic revenue growth and a 21% operating margin in FY2027, supported by its order book and further efficiency gains. That would put margins into its 21–23% medium-term target range sooner than expected. (Smiths Group)
The sales of Detection and Interconnect generated £3.3bn of enterprise value and left Smiths with £1.747bn of net cash. The simpler portfolio and planned further £1.5bn buyback give it financial flexibility and a substantial route to return capital to shareholders. (Reuters, Smiths Group)
The £165m DRC Heat Transfer acquisition adds cooling products and exposure to data-centre and power-generation markets. Those adjacencies could broaden Flex-Tek’s growth opportunities as demand for data-centre infrastructure expands. (Smiths Group)
Organic revenue grew just 1.2% in FY2026, while Flex-Tek declined 0.4%. Management’s roughly 4% FY2027 growth outlook remains below its 5–7% medium-term target, leaving delivery dependent on a meaningful improvement. (Smiths Group)
Middle East disruption cost John Crane about £20m in FY2026, and the FY2027 outlook assumes disruption continues in the first half. A prolonged interruption could delay the division’s expected recovery and weigh on group growth. (Reuters, Smiths Group)
The shares may already reflect much of the improvement: Citi downgraded Smiths to Neutral after a post-results rally, saying FY2027 guidance was broadly in line with expectations and near-term catalysts were limited. That leaves less obvious scope for gains if trading merely meets forecasts. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 19 Oct 2026.

Smiths Group Financial Performance

Revenues and expenses
Income statement
AnnuallyQuarterly
2023
YoY growth
Revenue
Net income
Profit margin

Smiths Group Earnings Performance

Company profitability
Earnings per share
AnnuallyQuarterly
2020
2021
2022
2023
2024
Actual
Expected
Surprise

Funds containing Smiths Group

AllUSDEURGBP
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.